Distinguishing pancreatic cancer from autoimmune pancreatitis.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 20424980)

Published in Curr Gastroenterol Rep on April 01, 2010

Authors

Aravind Sugumar1, Naoki Takahashi, Suresh T Chari

Author Affiliations

1: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. sugumar.aravind@mayo.edu

Articles by these authors

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00

Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70

International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33

Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92

Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69

EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61

Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49

Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35

Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29

Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28

Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition. Ann Surg (2013) 2.26

Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol (2011) 2.17

Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15

A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol (2009) 2.06

Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg (2008) 2.04

Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell (2005) 2.01

Severe acute pancreatitis. JAMA (2004) 2.00

Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas (2003) 1.96

Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92

Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol (2007) 1.83

Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg (2007) 1.76

MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol (2008) 1.69

Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68

Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut (2012) 1.67

Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64

Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery (2012) 1.64

EUS-guided pancreatic duct intervention: outcomes of a single tertiary-care referral center experience. Gastrointest Endosc (2013) 1.64

Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Clin Cancer Res (2006) 1.61

Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol (2011) 1.61

IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol (2006) 1.59

Classification and expression analysis of Arabidopsis F-box-containing protein genes. Plant Cell Physiol (2002) 1.59

Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block. Am J Gastroenterol (2007) 1.58

Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol (2004) 1.57

Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology (2007) 1.56

Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis. Pancreas (2003) 1.56

Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol (2009) 1.55

New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54

Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology (2011) 1.49

Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol (2011) 1.48

A comparison of direct endoscopic necrosectomy with transmural endoscopic drainage for the treatment of walled-off pancreatic necrosis. Gastrointest Endosc (2009) 1.47

ydk1-D, an auxin-responsive GH3 mutant that is involved in hypocotyl and root elongation. Plant J (2004) 1.46

Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology (2007) 1.45

Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci (2011) 1.43

Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg (2005) 1.42

Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol (2009) 1.39

Somatic and visceral solitary fibrous tumors in the abdomen and pelvis: cross-sectional imaging spectrum. Radiographics (2011) 1.38

Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol (2004) 1.36

Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2008) 1.35

Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Gastroenterology (2012) 1.34

Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am (2009) 1.27

Non-contrast renal artery MRA using an inflow inversion recovery steady state free precession technique (Inhance): comparison with 3D contrast-enhanced MRA. J Magn Reson Imaging (2010) 1.26

EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc (2005) 1.26

IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol (2010) 1.22

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer (2011) 1.20

Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis". Am J Gastroenterol (2009) 1.20

Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas (2011) 1.20

Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas (2009) 1.20

Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol (2013) 1.19

Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol (2013) 1.17

Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med (2005) 1.17

Impaired motor coordination in mice lacking neural recognition molecule NB-3 of the contactin/F3 subgroup. J Neurobiol (2003) 1.17

Endoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumors. Clin Gastroenterol Hepatol (2005) 1.16

Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer. Pancreatology (2005) 1.16

A series of luminescent Cu(I) mixed-ligand complexes containing 2,9-dimethyl-1,10-phenanthroline and simple diphosphine ligands. Dalton Trans (2006) 1.16

Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases. Gastrointest Endosc (2008) 1.16

Imaging of the seminal vesicle and vas deferens. Radiographics (2009) 1.15

Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol (2011) 1.14

Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol (2003) 1.14

The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer Genet Cytogenet (2008) 1.11

Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res (2006) 1.11

IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease. Hum Pathol (2012) 1.11

Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med (2014) 1.10

The Arabidopsis thaliana checkpoint kinase WEE1 protects against premature vascular differentiation during replication stress. Plant Cell (2011) 1.10

Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut (2013) 1.10

Requirement for Mab21l2 during development of murine retina and ventral body wall. Dev Biol (2004) 1.10

Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro. Kidney Int (2003) 1.09

Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology (2010) 1.08

Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia (2004) 1.08

Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin Proc (2007) 1.08

Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol (2009) 1.08

Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology (2013) 1.07

Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas (2003) 1.06

Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis (2009) 1.06

Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Am J Gastroenterol (2013) 1.05

Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol (2008) 1.04